Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
Our coverage here includes several modestly valued companies whose shares should recover strongly when the world re-opens for business. However, others may turn out to be classic value traps. Read on for our usual insightful comment.
James Halstead: another dividend increase
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREE
More on Anexo
Cosmetic ambiguity | Public sector winner and loser
News covered here includes our assessment of the latest trading update from a cosmetics group which…
Episode 16 of the Investor’s Champion Podcast
In this episode of the Investor’s Champion Podcast Chris and Lee run through key news from…
More on Brickability
Steady as ever | Decent value | Sweet returns
News covered here includes our review of positive results from an engineering services group and one…
Diworsification? | Accounting confusion | Contract demands
A provider of maritime surveillance systems is finally delivering on its considerable potential, although, with plenty…
More on Duke Capital
Trustpilot tanks | Nuclear returns | Dividend delights
Shares in highly-rated Trustpilot tumble as a short seller attacks the integrity of its reviews and…
BIG litigation | Big margins | Big dividends
News covered here includes our coverage of excellent results from a specialist medical device company, which…
More on Ideagen PLC
Bonkers deal of the week or another nifty acquisition?
The shares of technology stocks are plummeting, but that hasn’t stopped this AIM company paying what…
Strong updates to enjoy
Results and updates covered here include those of several consistent (and highly-rated) performers, but a potential…
More on iEnergizer
Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
Our coverage here includes several modestly valued companies whose shares should recover strongly when the world…
More on ITV
Income Boosters: cash-backed dividends with growth potential
Earnings season has been free of major drama for our high yielders, despite the uncertain macroeconomic…
Income Boosters: making progress in mixed markets
July was a busy month for our high yield Income Boosters portfolio, with five companies reporting during…
More on James Halstead
Angel delight | Cash flow drag | Restoring confidence
News covered here includes our assessment of results from two professional services groups, both of whom…
Another upgrade | 49 years of dividend increases
News covered in our update here include our thoughts on another strong trading update from a…
More on Manolete Partners
Another share buyback | Not suited to public markets
News covered here includes our assessment of the latest results from one of AIM’s largest companies.…
Episode 39 of the Investor’s Champion Podcast
In this episode of the Investors Champion Podcast, hosts Chris and Lee dive into the controversial…
More on WH Smith
Wine worries | Construction woes | Travel delights
News covered here includes our assessment of trading updates from AIM’s online wine retailers. While one…
Episode 21 of the Investor’s Champion Podcast
In this episode of the Investors Champion podcast, hosts Chris and Lee discuss the challenges faced…
